Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. (23rd March 2021)
- Record Type:
- Journal Article
- Title:
- Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. (23rd March 2021)
- Main Title:
- Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Authors:
- Kang, Chang Kyung
Kim, Minji
Lee, Soojin
Kim, Gwanghun
Choe, Pyoeng Gyun
Park, Wan Beom
Kim, Nam Joong
Lee, Chang-Han
Kim, Ik Soo
Jung, Keehoon
Lee, Dong-Sup
Shin, Hyun Mu
Kim, Hang-Rae
Oh, Myoung-don - Abstract:
- Abstract: Background: Understanding the memory T-cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for assessing the longevity of protective immunity after SARS-CoV-2 infection or coronavirus disease 2019 (COVID-19) vaccination. However, the longitudinal memory T-cell response up to 8 months post–symptom onset (PSO) according to the severity of illness is unknown. Methods: We analyzed peripheral blood mononuclear cells (PBMCs) from healthy volunteers or patients with COVID-19 who experienced asymptomatic, mild, or severe illness at 2, 5, and 8 months PSO. SARS-CoV-2 spike, nucleocapsid, and membrane protein-stimulated PBMCs were subjected to flow cytometry analysis. Results: A total of 24 patients (7 asymptomatic, 9 with mild disease, and 8 with severe disease) and 6 healthy volunteers were analyzed. SARS-CoV-2–specific OX40 + CD137 + CD4 + T cells and CD69 + CD137 + CD8 + T cells persisted at 8 months PSO. Also, antigen-specific cytokine-producing or polyfunctional CD4 + T cells were maintained for up to 8 months PSO. Memory CD4 + T-cell responses tended to be greater in patients who had severe illness than in those with mild or asymptomatic disease. Conclusions: Memory response to SARS-CoV-2, based on the frequency and functionality, persists for 8 months PSO. Further investigations involving its longevity and protective effect from reinfection are warranted. Abstract : Flow cytometric analyses showed frequent and functional memoryAbstract: Background: Understanding the memory T-cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for assessing the longevity of protective immunity after SARS-CoV-2 infection or coronavirus disease 2019 (COVID-19) vaccination. However, the longitudinal memory T-cell response up to 8 months post–symptom onset (PSO) according to the severity of illness is unknown. Methods: We analyzed peripheral blood mononuclear cells (PBMCs) from healthy volunteers or patients with COVID-19 who experienced asymptomatic, mild, or severe illness at 2, 5, and 8 months PSO. SARS-CoV-2 spike, nucleocapsid, and membrane protein-stimulated PBMCs were subjected to flow cytometry analysis. Results: A total of 24 patients (7 asymptomatic, 9 with mild disease, and 8 with severe disease) and 6 healthy volunteers were analyzed. SARS-CoV-2–specific OX40 + CD137 + CD4 + T cells and CD69 + CD137 + CD8 + T cells persisted at 8 months PSO. Also, antigen-specific cytokine-producing or polyfunctional CD4 + T cells were maintained for up to 8 months PSO. Memory CD4 + T-cell responses tended to be greater in patients who had severe illness than in those with mild or asymptomatic disease. Conclusions: Memory response to SARS-CoV-2, based on the frequency and functionality, persists for 8 months PSO. Further investigations involving its longevity and protective effect from reinfection are warranted. Abstract : Flow cytometric analyses showed frequent and functional memory T-cell response to severe acute respiratory syndrome coronavirus 2 for 8 months post–symptom onset. Memory CD4 + T-cell response tended to be greater in severe patients than in mild or asymptomatic patients. … (more)
- Is Part Of:
- Journal of infectious diseases. Volume 224:Number 1(2021)
- Journal:
- Journal of infectious diseases
- Issue:
- Volume 224:Number 1(2021)
- Issue Display:
- Volume 224, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 224
- Issue:
- 1
- Issue Sort Value:
- 2021-0224-0001-0000
- Page Start:
- 39
- Page End:
- 48
- Publication Date:
- 2021-03-23
- Subjects:
- memory response -- T-cell -- SARS-CoV-2 -- 8 months -- severity
Communicable diseases -- Periodicals
Diseases -- Causes and theories of causation -- Periodicals
Medicine -- Periodicals
Communicable Diseases -- Periodicals
Electronic journals
616.9 - Journal URLs:
- http://jid.oxfordjournals.org/content/by/year ↗
http://www.journals.uchicago.edu/JID/journal/ ↗
http://www.jstor.org/journals/00221899.html ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/infdis/jiab159 ↗
- Languages:
- English
- ISSNs:
- 0022-1899
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25861.xml